Recruitment platform connects heart failure patients with clinical trials

By Maggie Lynch contact

- Last updated on GMT

(Image: Getty/Urupong)
(Image: Getty/Urupong)

Related tags: Clinical trial, Clinical trial management, Recruitment

Through XpertDox’s partnership with the Heart Failure Society of America (HFSA), patients and clinicians will be able to track heart failure related clinical trials.

XpertDox’s clinical trial search and engagement platform XpertTrial was created to provide patients and health care providers with up-to-date information on actively recruiting clinical trials.

Kara Whelply, communications director at XpertDox, told us that the decision to partner was an easy one, as the HFSA sought, and continues to seek, a platform to expand heart failure care through collaboration.

“A central focus behind this effort is improving patient access to care by leveraging big data,”​ said Whelphly.

The platform is a natural language processing search engine designed to accelerate patient and clinician access to clinical trial data and information. It can match roughly 70,000 keywords across all diseases, procedures, symptoms, and specialties to recruiting clinical trials.

The specific proprietary algorithm uses big data to generate network mapping between diseases and clinical trials and will be used in the partnership to ensure the connection of heart failure patients and interested clinicians in recruiting trials.

“It is important for the heart failure community to specifically know about recruiting clinical trials because without their participation the development of new treatments, medications and innovations for heart failure will be severely delayed,”​ Whelply explained.

Related news

Show more

Related products

show more

Stability Testing As a Quality Control Measure

Stability Testing As a Quality Control Measure

Frontage Laboratories | 19-Jun-2019 | Technical / White Paper

Stability testing is, in essence, a quality control process and is there¬fore a vital component of every phase of clinical development for both large and...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us


View more